Diverchim CDMO is a French-based small molecule drug substance contract development and manufacturing organisation (CDMO) that specialises in the development and manufacturing of high-value new chemical entities (NCEs). With a firm commitment to quality and regulatory compliance, Diverchim CDMO provides comprehensive services tailored to the pharmaceutical industry, facilitating the transition from initial research to final product manufacturing.

Services include:
- Small Molecule, Drug Substance Manufacturing (API)
- Research & Development
- Regulatory Services
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Analytical Services
- Other bespoke manufacturing solutions as required

Diverchim CDMO stands as a vital partner in the pharmaceutical supply chain, offering expert services that support clients throughout the drug development process. For more information, please visit diverchim.com.